123 related articles for article (PubMed ID: 12646219)
1. Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II.
Noonpakdee W; Pothikasikorn J; Nimitsantiwong W; Wilairat P
Biochem Biophys Res Commun; 2003 Mar; 302(4):659-64. PubMed ID: 12646219
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
Föger F; Noonpakdee W; Loretz B; Joojuntr S; Salvenmoser W; Thaler M; Bernkop-Schnürch A
Int J Pharm; 2006 Aug; 319(1-2):139-46. PubMed ID: 16713146
[TBL] [Abstract][Full Text] [Related]
3. Non-sequence-specific antimalarial activity of oligodeoxynucleotides.
Clark DL; Chrisey LA; Campbell JR; Davidson EA
Mol Biochem Parasitol; 1994 Jan; 63(1):129-34. PubMed ID: 8183311
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.
Barker RH; Metelev V; Rapaport E; Zamecnik P
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):514-8. PubMed ID: 8552672
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum.
Wanidworanun C; Nagel RL; Shear HL
Mol Biochem Parasitol; 1999 Jul; 102(1):91-101. PubMed ID: 10477179
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligodeoxynucleotides: useful tool for search and assessment of new targets for anti-malarial drugs.
Ikemoto N; Kim HS; Kanazaki M; Ueno Y; Shuto S; Matsuda A; Wataya Y
Nucleic Acids Symp Ser; 1999; (42):89-90. PubMed ID: 10780393
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial antisense activity of hexitol nucleic acids.
Flores MV; Atkins D; Stewart TS; van Aerschot A; Herdewijn P
Parasitol Res; 1999 Oct; 85(10):864-6. PubMed ID: 10494816
[TBL] [Abstract][Full Text] [Related]
8. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
Yu XB; Fang JM; Luo SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):200-3. PubMed ID: 12567657
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum.
Auparakkitanon S; Wilairat P
Biochem Biophys Res Commun; 2000 Mar; 269(2):406-9. PubMed ID: 10708566
[TBL] [Abstract][Full Text] [Related]
11. Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II.
Bruxel F; Cojean S; Bochot A; Teixeira H; Bories C; Loiseau PM; Fattal E
Int J Pharm; 2011 Sep; 416(2):402-9. PubMed ID: 21291974
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum.
Rapaport E; Misiura K; Agrawal S; Zamecnik P
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8577-80. PubMed ID: 1528864
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA nanoparticle against malaria topoisomerase II.
Attasart P; Boonma S; Sunintaboon P; Tanwilai D; Pothikasikorn J; Noonpakdee WT
Exp Parasitol; 2016 May; 164():84-90. PubMed ID: 26953249
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target.
Suksangpleng T; Leartsakulpanich U; Moonsom S; Siribal S; Boonyuen U; Wright GE; Chavalitshewinkoon-Petmitr P
Malar J; 2014 Apr; 13():149. PubMed ID: 24742318
[TBL] [Abstract][Full Text] [Related]
16. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
17. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
Kublin JG; Cortese JF; Njunju EM; Mukadam RA; Wirima JJ; Kazembe PN; Djimdé AA; Kouriba B; Taylor TE; Plowe CV
J Infect Dis; 2003 Jun; 187(12):1870-5. PubMed ID: 12792863
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.
Gamage SA; Tepsiri N; Wilairat P; Wojcik SJ; Figgitt DP; Ralph RK; Denny WA
J Med Chem; 1994 May; 37(10):1486-94. PubMed ID: 8182707
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes.
Flores MV; Atkins D; Wade D; O'Sullivan WJ; Stewart TS
J Biol Chem; 1997 Jul; 272(27):16940-5. PubMed ID: 9202005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
